Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CARFILZOMIB vs CASIMERSEN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CARFILZOMIB vs CASIMERSEN: Safety Overview

Metric CARFILZOMIB CASIMERSEN
Total FAERS Reports 21,814 767
Deaths Reported 3,448 7
Death Rate 15.8% 0.9%
Hospitalizations 7,502 87
Average Patient Age 64.7 yrs 14.0 yrs
% Female Patients 42.6% 0.4%
FDA Approval Date Jul 20, 2012 Feb 25, 2021
Manufacturer Onyx Pharmaceuticals, Inc. Sarepta Therapeutics, Inc.
Route INTRAVENOUS N/A
Marketing Status Prescription Prescription